The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
Open accessAbstract
The transmembrane protein Tim-3 has been shown to negatively regulate T-cell-dependent immune responses and was recently demonstrated to be associated with the phenomenon of immune exhaustion, which can occur as a consequence of chronic viral infection. Unlike other negative regulators of T-cell function (e.g., PD-1), Tim-3 does not contain any obvious inhibitory signaling motifs. We have found that ectopic expression of Tim-3 in T cells leads to enhancement of T-cell receptor (TCR)-dependent signaling pathways, which was observed at the level of transcriptional reporters and endogenous cytokine production. We have exploited this observation to dissect what elements within the cytoplasmic tail of Tim-3 are required for coupling to downstream signaling pathways. Here we have demonstrated that two of the more membrane-proximal cytoplasmic tail tyrosines are required for Tim-3 signaling to T-cell activation pathways in a redundant fashion. Furthermore, we show that Tim-3 can directly bind to the Src family tyrosine kinase Fyn and the p85 phosphatidylinositol 3-kinase (PI3K) adaptor. Thus, at least under conditions of short-term stimulation, Tim-3 can augment T-cell activation, although this effect can be blocked by the inclusion of an agonistic antibody to Tim-3. These findings should help further the study of Tim-3 function in other physiological settings, such as those that lead to immune exhaustion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, tyrosine kinase FYN and human leukocyte antigen B (HLA‐B)‐associated transcript 3 (BAT3) were suggested to inhibit the cytoplasmic tail of TIM‐3 signaling [307, 308, 309].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [309]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,046
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Self-citationBlackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057
Self-citationScansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs
Obenauer, J. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg584 · Cited by 1,609
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,355
PD-1 and PD-1 ligands: from discovery to clinical application
Okazaki, T., & Honjo, T. (2007) · International Immunology · doi:10.1093/intimm/dxm057 · Cited by 1,310
Fourcade, J., Sun, Z., Benallaoua, M., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Kuchroo, V., & Zarour, H. M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100637 · Cited by 1,307
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Obenauer J. C., 2004, Methods Mol. Biol, 261, 445
Cited by
Sorted by citations
Items 201–282 of 282
Wang, X., Wang, S., Xu, X., Jiang, Y., Ren, L., Zhang, H., Li, Z., Liu, X., Hu, X., & Ren, Y. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06379-2 · Cited by 9
Co-inhibitory Receptor Signaling in T-Cell-Mediated Autoimmune Glomerulonephritis
Nagai, K. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.584382 · Cited by 9
Leveraging T cells for cancer immunotherapy
Bates, A., Fletcher, N. E., Gao, F., Pinho, M. P., & Dong, T. (2025) · Immunity & Inflammation · doi:10.1007/s44466-025-00007-z · Cited by 8
HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden–induced T-cell Exhaustion
Nguyen, A., Brown, D., Krishnan, R., Bastin, D. J., Deng, L., Chen, L., Salem, O., Walsh, S. R., Bramson, J. L., & Wan, Y. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2181 · Cited by 8
Endogenous antigens shape the transcriptome and TCR repertoire in an autoimmune arthritis model
McCarthy, E. E., Yu, S., Perlmutter, N., Nakao, Y., Naito, R., Lin, C., Riekher, V., DeRisi, J. L., Ye, C., Weiss, A., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174647 · Cited by 8
Small Molecular Immune Modulators as Anticancer Agents
Han, Y., Zhu, L., Wu, W., Zhang, H., Hu, W., Dai, L., & Yang, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_22 · Cited by 8
Ogando‐Rivas, E., Castillo, P., Jones, N. T., Trivedi, V. S., Drake, J. A., Dechkovskaia, A. M., Candelario, K. M., Yang, C., & Mitchell, D. A. (2022) · Microbiology and Immunology · doi:10.1111/1348-0421.12967 · Cited by 8
Immune checkpoint TIM-3 in tumor immunotherapy
Ma, S., Zhu, M., Ma, C., & Li, C. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025235 · Cited by 7
Prediction of the Peptide–TIM3 Binding Site in Inhibiting TIM3–Galectin 9 Binding Pathways
Odstrcil, R. E., Dutta, P., & Liu, J. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00487 · Cited by 7
The emerging role of TIM-3 in colorectal cancer: a promising target for immunotherapy
Karami, R., Fathi, M., Jalali, P., Hassannia, H., Zarei, A., Hojjat‐Farsangi, M., & Jadidi‐Niaragh, F. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2442437 · Cited by 6
Teagle, A. R., Castro-Sánchez, P., Brownlie, R. J., Logan, N., Kapoor, S. S., Wright, D., Salmond, R. J., & Zamoyska, R. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007614 · Cited by 6
Therapeutic potential of TIM-3 inhibition in cancer, viral infections, and autoimmune disorders
Manzoor, A., & Barakat, K. (2025) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2025.106826 · Cited by 6
Liu, Z., Chen, H., Tan, C., Zha, J., Liu, H., & Chen, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115551 · Cited by 6
Regulation of Tim-3 function by binding to phosphatidylserine
Kane, L. (2021) · Biochemical Journal · doi:10.1042/bcj20210652 · Cited by 6
Self-citationNieves-Rosado, H. M., Jacobs, J. L., Naqvi, A., Mellors, J. W., Macatangay, B. J. C., & Kane, L. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad068 · Cited by 5
Self-citationPhoswa, W. N., Khaliq, O. P., & Eche, S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20176627 · Cited by 5
Naïve arthritogenic SKG T cells have a defect in anergy and a repertoire pruned by superantigenPreprint
Ashouri, J. F., McCarthy, E. E., Yu, S., Perlmutter, N., Lin, C., DeRisi, J. L., Ye, C., & Weiss, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.13.476250 · Cited by 5
Uncovering NK cell sabotage in gut diseases via single cell transcriptomics
Lee, H., Ko, D. S., Heo, H. J., Baek, S. E., Kim, E. K., Kwon, E. J., Kang, J., Yu, Y., Baryawno, N., Kim, K., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315981 · Cited by 4
Tim-3 promotes viral infection by suppressing the USP25-TRAF3-IRF7 signaling pathway
Du, L., Chen, J., Du, C., Chen, J., Wang, Z., Bao, B., Zhonglin, L. V., Chen, X., Liang, M., Wang, L., et al. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.104930 · Cited by 4
Genome editing or small molecule inhibition of KMT5A in CAR-T cells enhances antitumor immunity
Tian, X., Liu, G., Wang, Q., Zhang, N., Shen, Y., Du, B., & Wu, Y. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012160 · Cited by 4
Zahran, A. M., Youssef, M. A. M., Elsayh, K. I., Embaby, M. M., & Ibrahim, A. I. M. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617730638 · Cited by 4
Gao, Y., Fan, X.-Z., Li, R., & Zhou, X. (2022) · Central European Journal of Immunology · doi:10.5114/ceji.2022.118778 · Cited by 4
Delova, A., Pasc, A., & Monari, A. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202304318 · Cited by 4
Hosseini-Valiki, F., Taghiloo, S., Tavakolian, G., Amjadi, O., Tehrani, M., Hedayatizadeh‐Omran, A., Alizadeh‐Navaei, R., Zaboli, E., Shekarriz, R., & Asgarian‐Omran, H. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.9.2615 · Cited by 4
Li, Y., Zheng, R., Pan, B., Wang, X., Zhang, L., Gao, H., & Li, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1713199 · Cited by 3
Gabel, M., Knauss, A., Neurath, M. F., & Weigmann, B. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02631-z · Cited by 3
Meyaard, L., & van der Vlist, M. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083024-025659 · Cited by 3
Emerging new immune checkpoint inhibitors in solid tumor immunotherapy
Poorkhani, A., Tajaldini, M., Ahmadi, F., Tahmasebifar, A., Azadehrah, M., Azadehrah, M., Ghamoushiramandi, A., Amiri, R. S., & Khori, V. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04131-w · Cited by 3
Shinkawa, T., Chang, E., Rakib, T., Cavallo, K., Lai, R., & Behar, S. M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116184 · Cited by 3
Immune Checkpoint Inhibitors in Cancer Immunotherapy
Hussain, F. H. N., & Raza, A. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-3976-3.ch004 · Cited by 3
Wang, Z., Xie, Z., Mou, Y., Geng, R., Chen, C., & Ke, N. (2024) · Cancer Medicine · doi:10.1002/cam4.70110 · Cited by 2
The concurrent silencing of Tim-3 and STAT-3 promotes tumor regression both in vitro and in ovo
Karami, R., Khodayari, S., Eshaghi, F. S., Ebrahimi, F., Khodakarami, A., Rashidi, B., Nikdel, M., Mehr, H. M., Kazemi, T., & Jadidi‐Niaragh, F. (2025) · BMC Cancer · doi:10.1186/s12885-025-14830-5 · Cited by 2
TIM-3 in AML: pathogenic roles and therapeutic targetability
Zhong, L., & Samarkhazan, H. S. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02133-3 · Cited by 2
The Signaling Networks of TIM-3, TGF-β, and STING in Glioblastoma
Ahmady, F., Carnie, B. M. H., Anderson, G. E. C., Achari, E., Sharma, A., Achuthan, A. A., Kannourakis, G., & Luwor, R. B. (2026) · Cells · doi:10.3390/cells15110991 · Cited by 2
Quamine, A. E., Dray, E. L., Mohrdieck, N. R., King, C. A., Griggs, A. A., Kline, J. M., Cho, M. M., Rinella, S., Tippins, K. E., Bates, P. D., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010239 · Cited by 2
Kikushige, Y. (2016) · PubMed · doi:10.11406/rinketsu.57.412 · Cited by 2
Gao, Y., Lu, Y., Fan, X.-Z., Wang, Y.-H., Tian, J., Saed, Y. A., Li, R., & Zhou, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108971 · Cited by 2
Stühler, V., Alemi, B., Rausch, S., Stenzl, A., Schwab, M. G., Schaeffeler, E., & Bedke, J. (2024) · World Journal of Urology · doi:10.1007/s00345-023-04721-4 · Cited by 1
Drivers of EMT and Immune Evasion
Brekken, R. A., & Wnuk-Lipińska, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_9 · Cited by 1
Tim-3 Is Not Required for Establishment of CD8+ T Cell Memory to Lymphocytic Choriomeningitis Virus
Manandhar, P., Szymczak-Workman, A. L., & Kane, L. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300401 · Cited by 1
Self-citationGayen, S., Mukherjee, S., Dasgupta, S., & Roy, S. (2024) · APOPTOSIS · doi:10.1007/s10495-024-02022-8 · Cited by 1
Drivers of EMT and Immune Evasion
Brekken, R. A., & Wnuk-Lipińska, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_11 · Cited by 1
Cong, Y., Cui, Y., Zhu, S., Cao, J., Qiao, G., Zou, H., Jiang, W. G., & Yu, Z. (2020) · doi:10.21203/rs.2.22315/v2 · Cited by 1
Tim-3 Promotes Early Differentiation of Tbet + Effector T Cells During Acute Viral InfectionPreprint
Manandhar, P., Landy, E., Mori, K., & Kane, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.08.663709 · Cited by 1
Self-citationRegulation of T cell responses by the surface receptor Tim-3
Gorman, J. V. (2014) · doi:10.17077/etd.pcnchex2
Tim-3 Regulation of Cancer Immunity
Sakuishi, K., & Anderson, A. C. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_8
Mechanisms of Tim-3 Signal Transduction in the Modulation of Downstream TCR Signaling
Lee, J. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Self-citationafter Influenza Infection Enhanced Tim3 Activity Improves Survival
Seed, B., Xavier, R. J., Cho, L., Roche, M. I., Sandall, B. P., & Abraham, L. (2012)
Running Title: Tim-3 function in human NK cells
Gleason, M., Lenvik, T. R., McCullar, V., Felices, M., Cooley, S., Verneris, M. R., Cichocki, F. M., Holman, C., Niki, T., Hirashima, M., et al. (2016)
Reversing T Cell Dysfunction for Tumor Immunotherapy
Kane, L., & Delgoffe, G. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-29827-6_5
Self-citationImmune checkpoint modulation: Tenets and implications in glioblastoma
Nduom, E. K.-E., Lynes, J. P., Sánchez, V., Nwankwo, A., & Dominah, G. A. (2019) · Glioma · doi:10.4103/glioma.glioma_47_18
Characterizing the Development of T cell Exhaustion Independent of PD-1
Freeman, Z. T. (2016)
Li, X. C. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717247855.792552804
Štěpánek, O. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736470481.793565345
Kane, L. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733797100.793578148
Self-citationCong, Y., Cui, Y., Zhu, S., Cao, J., Qiao, G., Zou, H., Jiang, W. G., & Yu, Z. (2020) · doi:10.21203/rs.2.22315/v1
Immunotherapy for Cervical Cancer
Gutiérrez‐Hoya, A., Valle‐Mendiola, A., & Soto‐Cruz, I. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_234-1
TIM-3 blockade as a therapeutic approach for diffuse intrinsic pontine glioma
Ausejo-Mauleón, I. (. (2023) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/69095
Other Immune Checkpoint Targets of Interest
Csizmar, C. M., & Ansell, S. M. (2024) · Wiley eBooks · doi:10.1002/9781119824572.ch12
The molecules with double-edged sword roles in T cell: An implication for adoptive T cell therapy
Samiee, M., Salehi, S., Khosroshahi, L. M., & Soltantoyeh, T. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104810
Immunotherapy for Cervical Cancer
Gutiérrez‐Hoya, A., Valle‐Mendiola, A., & Soto‐Cruz, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_234 · Cited by 1
Allela, O. Q. B., Shareef, A., Bishoyi, A. K., Oweis, R. J., Ballal, S., Singh, A., Sinha, A., Ray, S., Sameer, H. N., Yaseen, A., et al. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2571960
Wang, X., Wang, S., Xu, X., Jiang, Y., Ren, L., Zhang, H., Li, Z., Liu, X., Hu, X., & Ren, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26241333
Shapourian, H., Ghanadian, M., Eskandari, N., Shokouhi, A., Demirel, G. Y., Bazhin, A. V., & Ganjalikhani-Hakemi, M. (2024) · Figshare · doi:10.6084/m9.figshare.25059405
Wang, X., Wang, S., Xu, X., Jiang, Y., Ren, L., Zhang, H., Li, Z., Liu, X., Hu, X., & Ren, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26241247
Inhibitory receptor agonists: Emerging strategies in immune modulation
Adam, K. R., Suhail, A., Kuchroo, V. K., & Vignali, D. A. A. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20241217
Self-citationVinot, P.-A. (2018) · theses.fr (ABES) · doi:10.70675/8d700747z53d5z4ad2z91fbz840e35448ca7
Rôle de la Neuropiline-1 dans les fonctions effectrices des lymphocytes T CD8 antitumoraux
Leclerc, M. (2018) · theses.fr (ABES) · doi:10.70675/13aee211zad7bz4b07z9a5fz29b15750d99c
Défauts fonctionnels des cellules NK en contexte de stimulation chronique
Marotel, M. (2019) · theses.fr (ABES) · doi:10.70675/1dcb97a5za482z4664zaaf6z62a53817eea9
Role of co-activating receptors CD226 and CD137 in T cell exhaustion
Pichler, A. (2020) · theses.fr (ABES) · doi:10.70675/ec9fb2bazf7a9z4305z9a58zb5cbc6e74e63
The anti-tumoral effects of a low protein diet and of the IRE1α signaling
Turtos, A. M. (2022) · theses.fr (ABES) · doi:10.70675/fd90a3e8ze35az42fdzbd0ez966f12ddad22
TIM-3 in Cardiovascular Disease
Yousif, L. I. E., Sijtema, A. G., Chevalier, M. J., de Boer, R. A., & Meijers, W. C. (2026) · Current Heart Failure Reports · doi:10.1007/s11897-026-00755-y
Trioën, C. (2024) · theses.fr (ABES) · doi:10.70675/7c132518z8997z4d01z8084z87c06a661e5a
Tim-3 Sustains Tumor Treg Stability and Function, Limiting Checkpoint Blockade Therapy Efficacy
Banerjee, H., Onyekachi, O. V., Nieves-Rosado, H. M., Murter, B., Kulkarni, A., Pandey, S., Cardona, E., Dougherty, J. E., Li, H., Upadhyay, P., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0687
Self-citationSu, P., Zhang, Y., Yu, T., 王元宇, 牟一平, & Jin, W. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117338
Liu, Y., Dao, T., Borde, S., Dinh, D., Lombardi, S., Torregrosa‐Allen, S. E., Harper, H. A., Slivova, V., Cohen‐Gadol, A., McIntosh, M., et al. (2026) · Immunology · doi:10.1111/imm.70211
Metadata
- Authors
- Lee, J., Su, E. W., Zhu, C., Hainline, S., Phuah, J., Moroco, J. A., Smithgall, T. E., Kuchroo, V. K., & Kane, L. P.
- Affiliations
- University of Pittsburgh (US)
- Brigham and Women's Hospital (US)
- Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-10-01
- Volume
- 31
- Issue
- 19
- Pages
- 3963-3974
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3187355
- OpenAlex
- W2107777135
- Cited by
- 285
- References
- 39
- Citations by year
- 2026: 11 · 2025: 26 · 2024: 28 · 2023: 18 · 2022: 24 · 2021: 32 · 2020: 26 · 2019: 21 · 2018: 23 · 2017: 19 · 2016: 14 · 2015: 11 · 2014: 13 · 2013: 6 · 2012: 13
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM077629, GM077629)
- National Institute of Allergy and Infectious Diseases (R56AI067544, P01AI073748, AI067544, AI073748, R01AI067544)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- TIM-3, T cell receptor signaling, phosphotyrosine, immune exhaustion, T cell activation, Fyn, PI3K p85, chronic viral infection, agonistic antibodies
- MeSH terms
- Hepatitis A Virus Cellular Receptor 2, Amino Acid Sequence, Animals, Humans, Lymphocyte Activation, Membrane Proteins, Molecular Sequence Data, Phosphoproteins, Receptors, Antigen, T-Cell, T-Lymphocytes, Signal Transduction, NF-kappa B, Transcription Factor AP-1, Phosphotyrosine, src-Family Kinases, Jurkat Cells, Adaptor Proteins, Signal Transducing, NFATC Transcription Factors, Proto-Oncogene Proteins c-fyn, Mice, ZAP-70 Protein-Tyrosine Kinase, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
